Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart

Qiliqiangxin capsule is newly developed Chinese patent drug and proved to be effective and safe for the treatment of patients with chronic heart failure. We compared the effects of different dose Qiliqiangxin on L type Ca(2+) current (I (Ca-L)) between normal and hypertrophied myocytes. A total of 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yidong, Liu, Xiaoyu, Hou, Lei, Che, Wenliang, The, Erlinda, Jhummon, Muktanand Vikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320132/
https://www.ncbi.nlm.nih.gov/pubmed/22536279
http://dx.doi.org/10.1155/2012/131830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320132/
https://www.ncbi.nlm.nih.gov/pubmed/22536279
http://dx.doi.org/10.1155/2012/131830

Ejemplares similares